Lappe Mark
Reporting owner on Forms 3, 4 and 5, CIK 1366074.
Lappe Mark reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-09-28.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Inhibrx Biosciences, Inc. CIK 2007919 | director, officer (Chief Executive Officer) | 1 | 2026-09-28 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Inhibrx Biosciences, Inc. Common Stock | 2026-09-28 | P bought | +1,500 | $98.8803 | 737,548 | Form 4 |
| Inhibrx Biosciences, Inc. Common Stock | 2026-09-28 | P bought | +3,000 | $101.702 | 740,548 | Form 4 |
| Inhibrx Biosciences, Inc. Common Stock | 2026-09-25 | P bought | +3,324 | $98.8659 | 733,872 | Form 4 |
| Inhibrx Biosciences, Inc. Common Stock | 2026-09-25 | P bought | +2,176 | $99.5988 | 736,048 | Form 4 |
| Inhibrx Biosciences, Inc. Common Stock, holding | 165,000 | Form 4 | ||||
| Inhibrx Biosciences, Inc. Common Stock, holding | 54,865 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001366074-26-000004 | Inhibrx Biosciences, Inc. | 2026-09-28 |